<!DOCTYPE html>
<html lang="en"><head>

  <meta charset="utf-8">
  <title>Health is a Right</title>
  <meta name="keywords" content="">
  <meta name="description" content="">
  <meta name="viewport" content="width=device-width">

  <meta property="og:title" content="">
	<meta property="og:type" content="website">
	<meta property="og:url" content="">
	<meta property="og:site_name" content="">
	<meta property="og:description" content="">


  <link rel="stylesheet" href="css/font-awesome.min.css">
  <link rel="stylesheet" href="css/animate.css">
  <link href='http://fonts.googleapis.com/css?family=Dr+Sugiyama|Lato:400,100,100italic,300,300italic,400italic,700,700italic,900,900italic' rel='stylesheet' type='text/css'>


  <link rel="stylesheet" href="css/bootstrap.min.css">
  <link rel="stylesheet" href="css/main.css">

  <script src="js/modernizr-2.7.1.js"></script>
  <link rel="shortcut icon" href="img/favicon.png">


</head>

<body>

    <div class="navbar navbar-inverse navbar-static-top">
      <div class="container">
        <div class="navbar-header">
          <button type="button" class="navbar-toggle" data-toggle="collapse" data-target=".navbar-collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </button>
          <a class="navbar-brand" href="simulacrum.html"><img src="img/logo.png" alt="Logo"></a>
        </div>
        <div class="navbar-collapse collapse">
          <ul class="nav navbar-nav navbar-right">
            <li><a href="simulacrum.html">Simulacrum</a></li>
            <li><a href="problem.html">The Problem</a></li>
            <li><a href="cause.html">The Cause</a></li>
            <li><a href="solution.html">The Solution</a></li>
            <li><a href="action.html">What You Can Do</a></li>
          </ul>
        </div>
      </div>
    </div>



    <section id="main1">
      <div class="container">
        <div class="row">
          <div class="col-sm-6 margin-30">
            <h2>The Cause:</h2><br />
            <p> To understand how these drug prices are built, an understanding of the pharmaceutical market is necessary. This free market is divided into three sections: generic drugs, brand-name drugs with competitors, and brand-name drugs with no competitors. The generic drug market accounts for about 91% of prescribed drugs, but only 26% in total spending by drug manufacturers.
            </p><br />
            <p>
              In contrast, the brand-name drugs with no competitors market accounts for less than 2% of prescribed drugs, but an enormous 33% in total spending. The brand-name drugs with competitors may have a larger total spending percentage, but the proportion of prescribed drugs of the two former markets compared to the third is staggering. To put this into perspective, the average cost for a drug company to manufacture a specialty drug in this market is $1,674. </p><br />
            <br />
          </div>

          <div class="col-sm-6 wow fadeInUpBig">
            <img class="main1-img img-responsive pull-right" src="img/cause.png" alt="Main1 Image">
          </div>
        </div>
      </div>
    </section>


    <section id="main2">
      <div class="container">
        <div class="row">

          <div class="col-sm-6 wow fadeInUpBig">
            <img class="main2-img img-responsive pull-left" src="img/cause2.png" alt="Main2 Image">
          </div>

          <div class="col-sm-6 margin-30">
            <br/>
            <p>Additionally, many Americans see these high prices for specialty drugs as uncalled for, especially in the market where there are no competitors and the pharmaceutical company is able to run a pseudo-monopoly. In other words, the profit margin is unreasonably high. </p><br/>
            <br><p>To satiate consumers, pharmaceutical companies have agreed to limit the rights of manufacturing specialty drugs to a time period after which generic drug companies are able to market the significantly cheaper generic version. However, shady business practices such as “product hopping” by drug companies delay the entry of generic drugs. When a product is reformulated, the high price of the drug is maintained for a longer time than needed, which burdens patients, the government, and the American healthcare system. This monopolistic practice is harming consumers by keeping prices artificially inflated and is the cause of these high prices.</p>
            <br/>
          </div>

        </div>
      </div>
    </section>

    <footer>
      <div class="container">
        <div class="row">
          <div class="col-sm-12 text-center">
            <ul class="list-inline social">
              <li class="wow slideInLeft" data-wow-delay="0.3s"><a href="https://github.com/wdpark" target="_blank"><i class="fa fa-github fa-2x"></i></a></li>
            </ul>
            <p><small>@ William Park</small></p>
          </div>
        </div>
      </div>
    </footer>


    <script src="//ajax.googleapis.com/ajax/libs/jquery/2.1.0/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="js/jquery-2.1.0.min.js"><\/script>')</script>
    <script src="js/bootstrap.min.js"></script>
    <script src="js/wow.min.js"></script>
    <script src="js/main.js"></script>

    <script>
      new WOW().init();
    </script>


    </body>
</html>
